Unrelated Double Umbilical Cord Blood Units Transplantation
Status:
Unknown status
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and feasibility of unrelated double
umbilical cord blood units Transplantation in patients with haematological malignancies using
Antithymocyte Globulin Cyclophosphamide, busulfan as conditioning and cyclosporin,
methylprednisolone as GVHD prophylaxis.